1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Nidufexor: new trials by email Literature Review of Nidufexor trials Research Report on Nidufexor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy Nidufexor, Placebo, Standard of Care (SoC) - Diabetic Nephropathy | Phase 2 | Completed | Novartis Pharmaceuticals | 83 | 2018-12-17 | 2022-08-10 |
Diabetes Mellitus (1) · Diabetic Nephropathies (1)
Argentina (1) · Czechia (1) · Germany (1) · Jordan (1) · Lebanon (1) · Turkey (Türkiye) (1) · United States (1)
2018 (1)